Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

"Spinogenix’s Alzheimer’s drug touts disease-modifying potential in Phase IIa study" was originally created and published by ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer’s disease. Researchers found that a ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

A new statewide spatial analysis of Alzheimer's disease and related dementias (ADRD) has uncovered significant disparities in ...

UD's DementiaBank outshines global competitors, driving machine-learning advances in early dementia prediction ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

Scientists are finding that brain immune cells known as microglia with a specific mutation (at right) stayed young and avoided long-term inflammation that usually damages brain cells, conferring ...

For additional winter safety tips, click here. The Alzheimer’s Association offers a 24/7 helpline at (800) 272.3900 for free, confidential support, including guidance on safety planning. The West ...